Table 4.

Ability of the UCLA SCTC GITI to differentiate between degrees of severity of self-rated GI tract involvement.

Severity of GI Involvement According to Categorization of GI-S-HAQ Resultsp Values for Pairwise Differences Using Tukey’s Honestly Significant Differences Test
ScaleNormal, n = 62Mild-moderate, n = 34Severe, n = 17F TestpMild-moderate vs NormalSevere vs NormalSevere vs Mild-moderate
Reflux0.260.620.668.120.0010.0030.0100.951
Distension/bloating0.601.131.298.330.0000.0050.0040.754
Diarrhea0.180.410.747.830.0010.1040.0010.107
Fecal soilage0.160.620.536.120.0030.0040.1020.892
Constipation0.320.710.565.040.0080.0070.2990.669
Social functioning0.150.480.6213.510.0000.0000.0000.449
Emotional well-being0.140.560.9524.670.0000.0000.0000.013
Total UCLA SCTC GITI score0.250.640.8020.640.0000.0000.0000.312
  • UCLA SCTC GITI: University of California at Los Angeles Scleroderma Clinical Trial Consortium GI Tract Instrument; GI: gastrointestinal; GI-S-HAQ: GI scale of the Health Assessment Questionnaire for the Spondyloarthropathies.